Skip to main content
. 2010 Aug 23;1(6):273–278. doi: 10.1111/j.2040-1124.2010.00060.x

Table 3.  Odds ratios for diabetic micro‐ and macroangiopathies with anemia by a logistic regression analysis.

Grade 1 anemia Grade 2 anemia Total (grade 1 + 2) anemia
Wald χ2 score OR (95% CI) P Wald χ2 score OR (95% CI) P Wald χ2 score OR (95% CI) P
Unadjusted
 Nephropathy 33.5 2.22 (1.70–2.91) <0.01 40.2 4.60 (2.90–7.48) <0.01 59.1 2.65 (2.07–3.40) <0.01
 Retinopathy 28.4 2.70 (1.94–3.77) <0.01 34.6 4.77 (2.73–8.67) <0.01 51.9 3.07 (2.27–4.17) <0.01
 Neuropathy 10.1 2.12 (1.35–3.42) <0.01 8.6 4.01 (1.74–11.6) <0.01 16.6 2.43 (1.61–3.78) 0.01
 CVD 15.3 1.98 (1.40–2.78) <0.01 0.4 1.22 (0.64–2.17) 0.52 11.8 1.76 (1.27–2.42) <0.01
 CHD 22.7 2.20 (1.58–3.03) <0.01 23.4 3.21 (1.98–5.12) <0.01 33.4 2.40 (1.78–3.22) <0.01
 PAD 13.7 3.56 (1.82–7.07) <0.01 27.6 8.93 (4.16–19.0) <0.01 23.3 4.49 (2.48–8.47) <0.01
Adjusted*
 Retinopathy 11.4 1.93 (1.31–2.82) <0.01 3.8 1.97 (1.00–3.98) 0.049 13.1 1.93 (1.35–2.77) <0.01
 Neuropathy 0.4 1.18 (0.71–2.00) 0.53 2.8 2.56 (0.95–9.00) 0.09 1.4 1.35 (0.83–2.23) 0.23
 CVD 0.8 1.20 (0.81–1.75) 0.36 1.7 0.62 (0.29–1.23) 0.19 0.2 1.07 (0.74–1.55) 0.72
 CHD 7.4 1.64 (1.15–2.34) <0.01 8.1 2.28 (1.29–3.98) <0.01 10.6 1.74 (1.25–2.45) <0.01
 PAD 4.1 2.13 (1.02–4.52) 0.04 6.0 3.50 (1.30–9.19) 0.01 5.6 2.33 (1.17–4.78) <0.01
Adjusted**
 Retinopathy 10.1 2.13 (1.34–3.42) <0.01 0.1 0.93 (0.41–2.16) 0.86 8.4 1.92 (1.24–2.98) <0.01
 Neuropathy 0.0 1.02 (0.581.81) 0.95 1.3 2.07 (0.67–9.11) 0.26 0.1 1.10 (0.64–1.91) 0.73
 CVD 0.2 1.10 (0.67–1.81) 0.70 1.6 0.57 (0.22–1.31) 0.19 0.0 0.98 (0.60– .55) 0.89
 CHD 5.5 1.82 (1.09–2.71) 0.02 2.2 1.70 (0.83–3.37) 0.14 7.7 1.88 (1.19–2.80) <0.01
 PAD 4.1 2.18 (1.03–6.11) 0.04 5.2 2.74 (1.16–8.27) 0.03 4.2 2.44 (1.02–6.34) 0.04

CHD, coronary heart disease; CI, confidence interval; CVD, cerebrovascular disease; OR, odds ratio; PAD, peripheral arterial disease.

*Adjusted by age, sex, body mass index, use of angiotensin II receptor blocker, estimated glomerular filtration rate and stage of diabetic nephropathy (DN stage I, II and III + IV).

**Adjusted by age, sex, body mass index, duration of diabetes mellitus, current plus past smoking, hypertension, hyperlipidemia, use of ARB, estimated glomerular filtration rate and stage of diabetic nephropathy (DN stage I, II, and III + IV).